Amaninder Singh Dhillon’s Post

View profile for Amaninder Singh Dhillon, graphic

Experienced and Result-Driven Pharma Sales and Marketing Professional with Proven Expertise in Oncology: Strategic Go-To-Market Strategy, Dynamic Execution, Innovative New Launches, and P&L Management

Calling all Pharma Marketers! Unlock the power of patient testimonials in your promotional strategies! 👥 Gone are the days of generic advertisements. Today, authenticity reigns supreme, and what better way to showcase your product's impact than through the heartfelt stories of those it has touched? Patient testimonials provide a profound connection, resonating with your audience on a personal level. They breathe life into your brand, painting a vivid picture of real-world results. But it's not just about heartstrings; it's about data too! 📊 Collecting patient data is the cornerstone of evidence-based marketing. It's not just about anecdotes; it's about hard numbers backing up the claims. 📈 Take a cue from the legendary Mel Mann's recent LinkedIn post featuring the world's longest-living Gleevec survivor. 🏆 This powerful narrative showcases not only the effectiveness of the treatment but also the resilience of the human spirit. 💪 Now, the big question: Can other brands pick up this idea? By leveraging patient testimonials and robust data, every brand has the potential to inspire and empower. 🌟 #PharmaMarketing #PatientTestimonials #DataDrivenSuccess

View profile for Mel Mann, MBA, M.Ed, graphic

THE WORLD’S LONGEST LIVING GLEEVEC (Imatinib) & Tyrosine Kinase Inhibitor (TKI) & Kinase Inhibitor Survivor! Patient Advocate, 30 Yr Terminal CML Leukemia & AYA Survivor, Clinical Trials, Marrow Donation, Army Ret., ΩΨΦ

Gleevec’s Anniversary On 10 May 2001, #Gleevec (#Imatinib) was approved by the FDA for use in Chronic Myeloid Leukemia (CML) and made the cover of TIME Magazine. It now works for 11 different types of #cancer. I was blessed to enter the Gleevec phase 1 clinical trial when it began 3 years prior, in 1998, and I became the World’s Longest Living Gleevec Survivor. When I was first diagnosed, in January 1995, I was given 3 years to live. However, I was able to get “Today’s medicine Yesterday,” and that 3 years became 30 years. #ClinicalTrials are a way of getting “Tomorrow’s Medicine Today.” #ClinicalResearch #TKI

  • No alternative text description for this image
Prashant Menon

Strategy & Leadership Consultant; Executive Leadership & Team Coach; Founder Director at Workplace Dynamics; Co-Founder at The Bento Coach

5mo

So very vital to have these testimonials your way. Nothing endorses a brand or service better.

Mel Mann, MBA, M.Ed

THE WORLD’S LONGEST LIVING GLEEVEC (Imatinib) & Tyrosine Kinase Inhibitor (TKI) & Kinase Inhibitor Survivor! Patient Advocate, 30 Yr Terminal CML Leukemia & AYA Survivor, Clinical Trials, Marrow Donation, Army Ret., ΩΨΦ

5mo

Thanks for Sharing!

See more comments

To view or add a comment, sign in

Explore topics